Neoadjuvant Tamoxifen in Locally Advanced Breast Cancer in a Low/Middle Income Country

NCT02806544 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Breast Neoplasms

Interventions

DRUG: Tamoxifen

Sponsor

Vanderbilt University

Collaborators

[object Object]
[object Object]